Mercer Global Advisors
FHTX icon

Mercer Global Advisors’s Foghorn Therapeutics FHTX Stock Holding History

Mercer Global Advisors’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
+2,273
New +$10.1K ﹤0.01% 5086

Other funds holding FHTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mercer Global Advisors's FHTX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Foghorn Therapeutics (FHTX) in Q2 2026: 2,273 shares worth $11.1K. The stake represents ﹤0.01% of the portfolio and ranks #5086 among its holdings.

67 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Mercer Global Advisors held 2,273 shares of Foghorn Therapeutics worth $11.1K as of Q2 2026.
  • Foghorn Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5086 holding.
  • 67 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.